PORTA, Chiara
 Distribuzione geografica
Continente #
EU - Europa 2.367
NA - Nord America 1.952
AS - Asia 1.337
SA - Sud America 281
AF - Africa 49
Continente sconosciuto - Info sul continente non disponibili 9
OC - Oceania 2
Totale 5.997
Nazione #
US - Stati Uniti d'America 1.904
RU - Federazione Russa 551
SG - Singapore 426
IE - Irlanda 418
IT - Italia 301
DE - Germania 300
CN - Cina 278
SE - Svezia 257
HK - Hong Kong 210
BR - Brasile 203
VN - Vietnam 194
UA - Ucraina 153
FR - Francia 94
FI - Finlandia 77
EE - Estonia 76
IN - India 63
GB - Regno Unito 52
AR - Argentina 33
ID - Indonesia 29
CA - Canada 27
KR - Corea 27
BD - Bangladesh 20
TR - Turchia 20
ZA - Sudafrica 19
AT - Austria 18
BE - Belgio 16
NL - Olanda 15
IQ - Iraq 14
MX - Messico 14
BJ - Benin 13
EC - Ecuador 13
PL - Polonia 12
ES - Italia 8
EU - Europa 8
JP - Giappone 8
PK - Pakistan 8
SA - Arabia Saudita 8
CL - Cile 7
CO - Colombia 6
VE - Venezuela 6
PY - Paraguay 5
AE - Emirati Arabi Uniti 4
DZ - Algeria 4
MA - Marocco 4
PH - Filippine 4
CH - Svizzera 3
ET - Etiopia 3
IR - Iran 3
KZ - Kazakistan 3
LB - Libano 3
LT - Lituania 3
PE - Perù 3
PT - Portogallo 3
RO - Romania 3
TN - Tunisia 3
UZ - Uzbekistan 3
AU - Australia 2
AZ - Azerbaigian 2
BO - Bolivia 2
GT - Guatemala 2
JM - Giamaica 2
JO - Giordania 2
MD - Moldavia 2
UY - Uruguay 2
AO - Angola 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
CY - Cipro 1
DK - Danimarca 1
EG - Egitto 1
GY - Guiana 1
IL - Israele 1
KG - Kirghizistan 1
KH - Cambogia 1
LU - Lussemburgo 1
MT - Malta 1
MY - Malesia 1
NI - Nicaragua 1
NP - Nepal 1
OM - Oman 1
PA - Panama 1
QA - Qatar 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 5.997
Città #
Dublin 416
Jacksonville 275
Hong Kong 209
Dearborn 160
San Jose 156
Singapore 145
Ashburn 125
Los Angeles 105
Chandler 98
Piemonte 86
Moscow 77
Beijing 75
Council Bluffs 59
Wilmington 55
Lauterbourg 54
Ho Chi Minh City 52
Bremen 51
Lawrence 51
Princeton 51
Ann Arbor 50
Hanoi 45
San Mateo 35
Andover 32
Seoul 27
Milan 25
New York 25
Novara 23
Santa Clara 23
São Paulo 23
Buffalo 21
Frankfurt am Main 21
Orem 20
Nuremberg 19
Vercelli 19
Düsseldorf 17
Munich 16
Dallas 14
Cotonou 13
Brooklyn 12
Dong Ket 12
Nanjing 12
Poplar 12
Haiphong 11
Jakarta 11
Montreal 11
Redondo Beach 11
Turin 11
Brussels 10
Houston 10
Johannesburg 10
Rio de Janeiro 10
Amsterdam 9
Da Nang 9
Falkenstein 9
Hefei 9
Tianjin 9
Warsaw 9
Woodbridge 9
Barnet 8
Casalecchio Di Reno 8
Chennai 8
Denver 8
Guangzhou 8
Hangzhou 8
Kocaeli 8
Stockholm 8
Tokyo 8
Tornaco 8
Chicago 7
Mumbai 7
Norwalk 7
Porto Alegre 7
Shanghai 7
Toronto 7
Vienna 7
Atlanta 6
Busto Arsizio 6
Jeddah 6
London 6
New Delhi 6
Roubaix 6
Vaiano Cremasco 6
Boston 5
Guayaquil 5
Karbala 5
Manchester 5
Mexico City 5
Ninh Bình 5
Phoenix 5
Quito 5
Ankara 4
Baghdad 4
Biên Hòa 4
Boardman 4
Brasília 4
Buenos Aires 4
Can Tho 4
Changsha 4
Chengdu 4
Columbus 4
Totale 3.225
Nome #
The p50 NF-κB subunit is a prognostic regulator of colorectal cancer-associated inflammation 165
Inhibition of the histone methyltransferase ezh2 enhances protumor monocyte recruitment in human mesothelioma spheroids 157
Macrophage polarization in pathology 155
RORC1 Regulates Tumor-Promoting "Emergency" Granulo-Monocytopoiesis 141
Tumor-derived prostaglandin E2 promotes p50 NF-κB-dependent differentiation of monocytic MDSC. 141
Functions of diverse myeloid cells in the tumor micro-environment 135
Pro-tumor steering of cancer inflammation by p50 NF-κB enhances colorectal cancer progression 133
The Macrophages-Microbiota Interplay in Colorectal Cancer (CRC)-Related Inflammation: Prognostic and Therapeutic Significance 131
Neutralization of extracellular NAMPT (nicotinamide phosphoribosyltransferase) ameliorates experimental murine colitis 130
Hypoxia-mediated regulation of macrophage functions in pathophysiology 125
Metabolic influence on the differentiation of suppressive myeloid cells in cancer. 124
Metabolic regulation of suppressive myeloid cells in cancer 123
Molecular and epigenetic basis of macrophage polarized activation 123
Tumor-associated myeloid cells: new understandings on their metabolic regulation and their influence in cancer immunotherapy 122
Differential role of Interleukin-1 and Interleukin-6 in K-Ras-driven pancreatic carcinoma undergoing mesenchymal transition. 121
NAMPT: A pleiotropic modulator of monocytes and macrophages 121
Hypoxia-mediated regulation of macrophage functions in pathophysiology. 119
Myeloid-derived suppressor cells: Ductile targets in disease 117
Cell-specific regulation of PTX3 by glucocorticoid hormones in hematopoietic and non-hematopoietic cells 116
Macrophage polarization in tumour progression 115
Mutation analysis of the inhibin alpha gene in a cohort of Italian women affected by ovarian failure 113
LPS-tolerant monocytes/macrophages express a distinct M2 functional profile 113
IL-10 limits production of pathogenic TNF by M1 myeloid cells through induction of nuclear NF-κB p50 member in Trypanosoma congolense infection-resistant C57BL/6 mice 109
Interferons alpha and gamma induce p53-dependent and p53-independent apoptosis, respectively 108
Recent advances in biomedical, therapeutic and pharmaceutical applications of microbial surfactants 104
Inflammation and cancer: breast cancer as a prototype 102
Cellular and molecular pathways linking inflammation and cancer 102
Targeting nicotinamide phosphoryltransferase (NAMPT) in inflammatory bowel disease 102
convergent pathways of macrophage polarization: the role of B cells 100
Macrophages in cancer and infectious diseases: the 'good' and the 'bad'. 98
Extracellular nicotinamide phosphoribosyltransferase boosts IFNγ-induced macrophage polarization independently of TLR4 97
Benefits and Challenges of Inhibiting EZH2 in Malignant Pleural Mesothelioma 96
The p50 subunit of NF-?B orchestrates dendritic cell lifespan and activation of adaptive immunity. 93
Tumor-Associated Macrophages as new target in anticancer therapy 92
Evolution and Targeting of Myeloid Suppressor Cells in Cancer: A Translational Perspective. 89
Origin and Functions of Tumor-Associated Myeloid Cells (TAMCs) 87
Cannabinoid-free Cannabis sativa L. (chemotype V) as a polyphenol-rich source with antioxidant and anti-inflammatory activities. 86
Mechanisms linking pathogens-associated inflammation and cancer 84
Mutations in the coding region of the FOXL2 gene are not a major cause of idiopathic premature ovarian failure 84
The p50 NF-kappa B subunit controls dendritic cell survival and immunogenicity 81
Mechanisms linking pathogens-associated inflammation and cancer 79
Tolerance and M2 (alternative) macrophage polarization are related processes orchestrated by p50 nuclear factor κB 79
Targeting the antioxidant, antimicrobial and anti-inflammatory activity of non-psychotropic Cannabis sativa L.: a comparison with chemotype V 77
Tumor promotion by tumor-associated macrophages 77
Tumor-associated myeloid cells as guiding forces of cancer cell stemness 77
p50 NF-κB overexpression in Tumor Associated Macrophages inhibits M1 inflammatory responses and antitumor resistance 76
Tolerance and M2 (alternative) macrophage polarization are related processes orchestrated by p50 NF-kappaB 76
p50 NF-kappaB OVEREXPRESSION IN TUMOR ASSOCIATED MACROPHAGES INHIBITS M1 INFLAMMATORY RESPONSES AND ANTITUMOR RESISTANCE 76
The inflammatory micro-environment in tumor progression: the role of tumor-associated macrophages. 76
The PYRIN domain is required for TLR4-mediated inflammation by PYHIN family members 75
Role of p50 NF-kappaB in dendritic cells functions 74
Role of tumor-associated macrophages in tumor progression and invasion 74
Targeting tumour-associated macrophages 71
Role of Tumor-Associated Macrophages (TAM) in Cancer Related Inflammation 70
p50 nuclear factor-kappaB overexpression in tumor-associated macrophages inhibits M1 inflammatory responses and antitumor resistance 69
p50 NF-kappa B overexpression in tumor associated macrophages inhibits M1 inflammatory responses and antitumor resistance 66
The p50 subunit of NF-κB orchestrates dendritic cell lifespan and activation of adaptive immunity 66
Editorial: New insights into innate immune cell-based immunotherapies in cancer 65
Editorial: Focus on malignant pleural mesothelioma immunology and immunotherapy 57
Lower Expression of SARS-CoV-2 Host Cell Entry Genes in the Intestinal Mucosa of IBD Patients With Quiescent or Mildly Active Disease 47
Determinants of Response to Immune Checkpoint Blockade in Pleural Mesothelioma: Molecular, Immunological, and Clinical Perspectives. 44
The Dual Role of ACE2 in IBD: Balancing SARS-CoV-2 Susceptibility and Gut Homeostasis. 37
Totale 6.062
Categoria #
all - tutte 27.878
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.878


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202116 0 0 0 0 0 0 0 0 0 0 0 16
2021/2022372 5 2 52 86 14 1 40 9 28 6 50 79
2022/2023890 54 43 37 12 89 88 11 68 436 4 32 16
2023/2024247 18 15 20 9 43 2 73 8 0 4 8 47
2024/2025848 24 4 50 8 17 83 51 116 173 163 15 144
2025/20262.516 65 81 200 414 298 163 294 417 180 215 159 30
Totale 6.062